Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
197
-
Total 13F shares, excl. options
-
79.8M
-
Shares change
-
-5.16M
-
Total reported value, excl. options
-
$2.44B
-
Value change
-
-$156M
-
Put/Call ratio
-
1.74
-
Number of buys
-
120
-
Number of sells
-
-82
-
Price
-
$30.58
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q2 2024
233 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q2 2024.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.8M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (8.97M shares), WELLINGTON MANAGEMENT GROUP LLP (8.21M shares), BlackRock Inc. (7.77M shares), RTW INVESTMENTS, LP (7.39M shares), ARMISTICE CAPITAL, LLC (6.96M shares), COWEN AND COMPANY, LLC (3.76M shares), Camber Capital Management LP (3.5M shares), JANUS HENDERSON GROUP PLC (2.98M shares), STATE STREET CORP (2.75M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.79M shares).
This table shows the top 197 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.